Use of antibody-ligand binding to characterise diseases

Details for Australian Patent Application No. 2006246017 (hide)

Owner Novartis AG

Inventors Pascoe, Steve; Lowe, Phil; Lloyd, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2006246017

PCT Pub. Number WO2006/119942

Priority 0509512.0 10.05.05 GB

Filing date 8 May 2006

Wipo publication date 16 November 2006

International Classifications

G01N 33/536 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with immune complex formed in liquid phase

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/119942 Priority application(s): WO2006/119942

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006246025-Multilayered board

2006246010-Polyolefinic molding composition having improved resistance to thermooxidative degradation and its use for the production of pipes